Revenue
Total Revenue
Alnylam Pharmaceuticals Total Revenue increased by 6.4% to $1.17B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 96.4%, from $594.19M to $1.17B. Over 4 years (FY 2021 to FY 2025), Total Revenue shows an upward trend with a 44.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionRevenue
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
An increase indicates growing market demand or successful price increases, while a decrease suggests market saturation or competitive pressure.
Detailed definition
The total amount of income generated by the sale of goods or services related to the company's primary operations. For a...
Peer comparison
Peer technology firms typically report this as Net Sales or Total Revenue, reflecting the scale of their market reach.
Metric ID:
total_revenueHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $220.55M | $187.63M | $258.54M | $213.26M | $224.82M | $264.31M | $335.04M | $319.29M | $318.75M | $750.53M | $439.72M | $494.33M | $659.83M | $500.92M | $593.17M | $594.19M | $773.69M | $1.25B | $1.10B | $1.17B |
| QoQ Change | — | -14.9% | +37.8% | -17.5% | +5.4% | +17.6% | +26.8% | -4.7% | -0.2% | +135.5% | -41.4% | +12.4% | +33.5% | -24.1% | +18.4% | +0.2% | +30.2% | +61.4% | -12.2% | +6.4% |
| YoY Change | — | — | — | — | +1.9% | +40.9% | +29.6% | +49.7% | +41.8% | +184.0% | +31.2% | +54.8% | +107.0% | -33.3% | +34.9% | +20.2% | +17.3% | +149.3% | +84.9% | +96.4% |
Range$187.63M – $1.25B
CAGR+42.0%
Avg YoY Growth+56.9%
Median YoY Growth+41.3%
Total Revenue at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's total revenue?
- Alnylam Pharmaceuticals (ALNY) reported total revenue of $1.17B in Q1 2026.
- How has Alnylam Pharmaceuticals's total revenue changed year-over-year?
- Alnylam Pharmaceuticals's total revenue increased by 96.4% year-over-year, from $594.19M to $1.17B.
- What is the long-term trend for Alnylam Pharmaceuticals's total revenue?
- Over 4 years (2021 to 2025), Alnylam Pharmaceuticals's total revenue has grown at a 44.8% compound annual growth rate (CAGR), from $844.29M to $3.71B.
- What does total revenue mean?
- The total amount of money a company brings in from selling its products and services.